505 — Asiamedic Income Statement
0.000.00%
Last trade - 00:00
- SG$12.70m
- SG$12.55m
- SG$23.51m
- 36
- 79
- 51
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19 | 15.3 | 18.3 | 18.9 | 23.5 |
Cost of Revenue | |||||
Gross Profit | 17.3 | 14 | 16.9 | 17.4 | 21.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20.1 | 19.9 | 17.9 | 17.2 | 22.9 |
Operating Profit | -1.15 | -4.67 | 0.358 | 1.7 | 0.585 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.588 | -4.3 | 0.715 | 2.19 | 1.03 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.588 | -4.3 | 0.715 | 2.19 | 1.92 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.588 | -4.3 | 0.715 | 2.19 | 1.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.588 | -4.3 | 0.715 | 2.19 | 1.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | 0.002 | 0.002 | 0.001 | 0.002 |